Research ExplorerPublications[Malignant testicular tumors in children and adolescents: co...

[Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]

Standard

[Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]. / Haas, R J; Brämswig, J; Göbel, U; Harms, D; Janka-Schaub, Gritta; Weissbach, L.

In: KLIN PADIATR, Vol. 195, No. 3, 3, 1983, p. 196-200.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Haas, RJ, Brämswig, J, Göbel, U, Harms, D, Janka-Schaub, G & Weissbach, L 1983, '[Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]', KLIN PADIATR, vol. 195, no. 3, 3, pp. 196-200. <http://www.ncbi.nlm.nih.gov/pubmed/6192280?dopt=Citation>

APA

Haas, R. J., Brämswig, J., Göbel, U., Harms, D., Janka-Schaub, G., & Weissbach, L. (1983). [Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]. KLIN PADIATR, 195(3), 196-200. [3]. http://www.ncbi.nlm.nih.gov/pubmed/6192280?dopt=Citation

Vancouver

Haas RJ, Brämswig J, Göbel U, Harms D, Janka-Schaub G, Weissbach L. [Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]. KLIN PADIATR. 1983;195(3):196-200. 3.

Bibtex

@article{e440b9deeb3847f0a711facd58d58fe0,
title = "[Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]",
abstract = "The German Society of Pediatric Oncology (GPO) designed a cooperative study to improve the outlook of patients with malignant (testicular) germ cell tumors. According to stage and histology of the tumor different surgical approaches to retroperitoneal lymphadenectomy are suggested. Local radiotherapy is not recommended. Adjuvant chemotherapy with Vinblastine, Bleomycin and Cis-Platinum according to stage of disease, histologic classification and age of the patient is outlined. For non-responders or patients with only partial response an alternative aggressive chemotherapy with VP 16, Ifosfamide and Cis-Platinum is guidelined.",
author = "Haas, {R J} and J Br{\"a}mswig and U G{\"o}bel and D Harms and Gritta Janka-Schaub and L Weissbach",
year = "1983",
language = "Deutsch",
volume = "195",
pages = "196--200",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - [Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology]

AU - Haas, R J

AU - Brämswig, J

AU - Göbel, U

AU - Harms, D

AU - Janka-Schaub, Gritta

AU - Weissbach, L

PY - 1983

Y1 - 1983

N2 - The German Society of Pediatric Oncology (GPO) designed a cooperative study to improve the outlook of patients with malignant (testicular) germ cell tumors. According to stage and histology of the tumor different surgical approaches to retroperitoneal lymphadenectomy are suggested. Local radiotherapy is not recommended. Adjuvant chemotherapy with Vinblastine, Bleomycin and Cis-Platinum according to stage of disease, histologic classification and age of the patient is outlined. For non-responders or patients with only partial response an alternative aggressive chemotherapy with VP 16, Ifosfamide and Cis-Platinum is guidelined.

AB - The German Society of Pediatric Oncology (GPO) designed a cooperative study to improve the outlook of patients with malignant (testicular) germ cell tumors. According to stage and histology of the tumor different surgical approaches to retroperitoneal lymphadenectomy are suggested. Local radiotherapy is not recommended. Adjuvant chemotherapy with Vinblastine, Bleomycin and Cis-Platinum according to stage of disease, histologic classification and age of the patient is outlined. For non-responders or patients with only partial response an alternative aggressive chemotherapy with VP 16, Ifosfamide and Cis-Platinum is guidelined.

M3 - SCORING: Zeitschriftenaufsatz

VL - 195

SP - 196

EP - 200

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 3

M1 - 3

ER -